Details of the Drug Formulaction

General Information of Drug Formulation (ID: F01329)

• Formulation Name: Anagrelide 0.5 mg capsule
• Company: Torrent Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Anagrelide	(DMSQ8MD)	Thrombocythemia	3B63	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Ferrosoferric oxide	(E00231)	14789	Colorant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Potassium hydroxide	(E00233)	14797	Alkalizing agent
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent